MODULATION THERAPEUTICS, INC.

Organization

morgantown, WV, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Cyclic peptide compounds and methods of use thereof
- Patent number 12,060,438
- Issue date Aug 13, 2024
- Modulation Therapeutics, Inc.
- Mark McLaughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
RADIOTHERAPEUTIC AND COMPANION IMAGING AGENTS TO TARGET MC1R
- Publication number 20230211022
- Publication date Jul 6, 2023
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- David MORSE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYCLIC PEPTIDE COMPOUNDS AND METHODS OF USE THEREOF
- Publication number 20210347826
- Publication date Nov 11, 2021
- MODULATION THERAPEUTICS, INC.
- Mark MCLAUGHLIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RADIOTHERAPEUTIC AND COMPANION IMAGING AGENTS TO TARGET MC1R
- Publication number 20200108159
- Publication date Apr 9, 2020
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- David MORSE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
88276673 - CAPTOSIS
- Serial number 88276673
- Filing date Jan 25, 2019
- Modulation Therapeutics, Inc.
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry

NIH Research Projectlast 12 months

processing...

Count: 19

Research Projects

Information Research Project
Mechanism underpinning synergy with combined treatment of MTI-101 a...
- Application id 10080460
- Award notice date Jul 15, 2020
Information Research Project
Development of PEGylated MTI-101 for the treatment of relapsed Myeloma
- Application id 9775135
- Award notice date Aug 29, 2019
Information Research Project
Novel SCD1 inhibitors for treatment of cancer
- Application id 9768370
- Award notice date Aug 9, 2019
Information Research Project
Development of PEGylated MTI-101 for the treatment of relapsed Myeloma
- Application id 9979036
- Award notice date Jul 24, 2019
Information Research Project
Development of mitoNEET agonists for the treatment of stroke
- Application id 9674196
- Award notice date Feb 14, 2019
Information Research Project
Development of an a MC1R selective companion diagnostic imaging probe
- Application id 9680950
- Award notice date Sep 18, 2018
Information Research Project
Development of PEGylated MTI-101 for the treatment of relapsed Myeloma
- Application id 9769187
- Award notice date Sep 3, 2018
Information Research Project
Novel SCD1 inhibitors for treatment of cancer
- Application id 9621524
- Award notice date Aug 22, 2018
Information Research Project
Development of PEGylated MTI-101 for the treatment of relapsed Myeloma
- Application id 9662742
- Award notice date May 25, 2018
Information Research Project
Development of PEGylated MTI-101 for the treatment of relapsed Myeloma
- Application id 9409134
- Award notice date Sep 25, 2017
Information Research Project
Osteopontin-targeted therapy for primary CNS lymphoma
- Application id 9342631
- Award notice date Aug 28, 2017
Information Research Project
Novel SCD1 inhibitors for treatment of cancer
- Application id 9048181
- Award notice date Mar 5, 2016
Information Research Project
Targeting CD137L to MC1R-Expressing Melanoma Cells and Tumors.
- Application id 8905409
- Award notice date Jul 24, 2015
Information Research Project
Second generation MTI-101 analogs using a novel peptoid-peptide hyb...
- Application id 8647342
- Award notice date Jun 4, 2014
Information Research Project
Increasing the efficacy of MTI-101 in MM using Ab conjugation strat...
- Application id 8591600
- Award notice date Jul 31, 2013
Information Research Project
Targeting CD44 in the bone marrow microenvironment of MM
- Application id 8453303
- Award notice date Sep 26, 2012
Information Research Project
Chemical Optimization Designed to Increase the in vivo Efficacy of...
- Application id 8395611
- Award notice date Aug 23, 2012
Information Research Project
Targeted radiopharmaceuticals for uveal and metastatic melanoma
- Application id 9162466
Information Research Project
Targeted Ac-225-radiopharmaceutical for metastatic uveal melanomaPe...
- Application id 9576556

MODULATION THERAPEUTICS, INC.

Organization

Patents Grantslast 30 patents

Cyclic peptide compounds and methods of use thereof

Patents Applicationslast 30 patents

RADIOTHERAPEUTIC AND COMPANION IMAGING AGENTS TO TARGET MC1R

CYCLIC PEPTIDE COMPOUNDS AND METHODS OF USE THEREOF

RADIOTHERAPEUTIC AND COMPANION IMAGING AGENTS TO TARGET MC1R

Trademarklast 30 trademarks

88276673 - CAPTOSIS

NIH Research Projectlast 12 months

Research Projects

Mechanism underpinning synergy with combined treatment of MTI-101 a...

Development of PEGylated MTI-101 for the treatment of relapsed Myeloma

Novel SCD1 inhibitors for treatment of cancer

Development of PEGylated MTI-101 for the treatment of relapsed Myeloma

Development of mitoNEET agonists for the treatment of stroke

Development of an a MC1R selective companion diagnostic imaging probe

Development of PEGylated MTI-101 for the treatment of relapsed Myeloma

Novel SCD1 inhibitors for treatment of cancer

Development of PEGylated MTI-101 for the treatment of relapsed Myeloma

Development of PEGylated MTI-101 for the treatment of relapsed Myeloma

Osteopontin-targeted therapy for primary CNS lymphoma

Novel SCD1 inhibitors for treatment of cancer

Targeting CD137L to MC1R-Expressing Melanoma Cells and Tumors.

Second generation MTI-101 analogs using a novel peptoid-peptide hyb...

Increasing the efficacy of MTI-101 in MM using Ab conjugation strat...

Targeting CD44 in the bone marrow microenvironment of MM

Chemical Optimization Designed to Increase the in vivo Efficacy of...

Targeted radiopharmaceuticals for uveal and metastatic melanoma

Targeted Ac-225-radiopharmaceutical for metastatic uveal melanomaPe...